annual cash & cash equivalents:
$183.40M-$304.90M(-62.44%)Summary
- As of today (June 19, 2025), BRKR annual cash & cash equivalents is $183.40 million, with the most recent change of -$304.90 million (-62.44%) on December 31, 2024.
- During the last 3 years, BRKR annual cash & cash equivalents has fallen by -$884.80 million (-82.83%).
- BRKR annual cash & cash equivalents is now -82.83% below its all-time high of $1.07 billion, reached on December 31, 2021.
Performance
BRKR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$184.20M+$800.00K(+0.44%)Summary
- As of today (June 19, 2025), BRKR quarterly cash & cash equivalents is $184.20 million, with the most recent change of +$800.00 thousand (+0.44%) on March 31, 2025.
- Over the past year, BRKR quarterly cash & cash equivalents has dropped by -$155.90 million (-45.84%).
- BRKR quarterly cash & cash equivalents is now -82.76% below its all-time high of $1.07 billion, reached on December 31, 2021.
Performance
BRKR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BRKR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -62.4% | -45.8% |
| 3 y3 years | -82.8% | -77.4% |
| 5 y5 years | -73.0% | -76.8% |
BRKR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -82.8% | at low | -77.4% | +24.4% |
| 5 y | 5-year | -82.8% | at low | -82.8% | +24.4% |
| alltime | all time | -82.8% | +7406.9% | -82.8% | +8007.4% |
BRKR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $184.20M(+0.4%) |
| Dec 2024 | $183.40M(-62.4%) | $183.40M(+23.8%) |
| Sep 2024 | - | $148.10M(-12.7%) |
| Jun 2024 | - | $169.70M(-50.1%) |
| Mar 2024 | - | $340.10M(-30.4%) |
| Dec 2023 | $488.30M(-24.4%) | $488.30M(+34.3%) |
| Sep 2023 | - | $363.60M(-36.7%) |
| Jun 2023 | - | $574.80M(-3.9%) |
| Mar 2023 | - | $597.90M(-7.4%) |
| Dec 2022 | $645.50M(-39.6%) | $645.50M(+3.1%) |
| Sep 2022 | - | $626.20M(-13.4%) |
| Jun 2022 | - | $723.00M(-11.4%) |
| Mar 2022 | - | $816.10M(-23.6%) |
| Dec 2021 | $1.07B(+56.7%) | $1.07B(+86.4%) |
| Sep 2021 | - | $573.00M(-5.8%) |
| Jun 2021 | - | $608.10M(-12.7%) |
| Mar 2021 | - | $696.80M(+2.2%) |
| Dec 2020 | $681.80M(+0.5%) | $681.80M(+20.2%) |
| Sep 2020 | - | $567.10M(-24.1%) |
| Jun 2020 | - | $746.80M(-6.1%) |
| Mar 2020 | - | $795.50M(+17.3%) |
| Dec 2019 | $678.30M(+110.4%) | $678.30M(+128.9%) |
| Sep 2019 | - | $296.30M(+4.9%) |
| Jun 2019 | - | $282.50M(-5.5%) |
| Mar 2019 | - | $298.80M(-7.3%) |
| Dec 2018 | $322.40M(-0.8%) | $322.40M(+19.4%) |
| Sep 2018 | - | $270.10M(+4.4%) |
| Jun 2018 | - | $258.70M(-8.9%) |
| Mar 2018 | - | $283.90M(-12.6%) |
| Dec 2017 | $325.00M(-5.1%) | $325.00M(+23.2%) |
| Sep 2017 | - | $263.90M(+21.2%) |
| Jun 2017 | - | $217.70M(-21.5%) |
| Mar 2017 | - | $277.50M(-19.0%) |
| Dec 2016 | $342.40M(+28.2%) | $342.40M(+22.9%) |
| Sep 2016 | - | $278.70M(+19.9%) |
| Jun 2016 | - | $232.50M(+10.8%) |
| Mar 2016 | - | $209.90M(-21.4%) |
| Dec 2015 | $267.10M(-16.4%) | $267.10M(-19.3%) |
| Sep 2015 | - | $331.00M(+3.2%) |
| Jun 2015 | - | $320.80M(-4.1%) |
| Mar 2015 | - | $334.50M(+4.7%) |
| Dec 2014 | $319.50M(-27.2%) | $319.50M(-2.9%) |
| Sep 2014 | - | $329.20M(-15.5%) |
| Jun 2014 | - | $389.80M(-14.1%) |
| Mar 2014 | - | $454.00M(+3.5%) |
| Dec 2013 | $438.70M(+41.2%) | $438.70M(+43.0%) |
| Sep 2013 | - | $306.80M(+22.3%) |
| Jun 2013 | - | $250.90M(-6.9%) |
| Mar 2013 | - | $269.40M(-13.3%) |
| Dec 2012 | $310.60M | $310.60M(+28.3%) |
| Sep 2012 | - | $242.10M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $240.30M(+4.7%) |
| Mar 2012 | - | $229.50M(-6.7%) |
| Dec 2011 | $246.00M(+6.8%) | $246.00M(+25.6%) |
| Sep 2011 | - | $195.80M(+15.3%) |
| Jun 2011 | - | $169.80M(-12.2%) |
| Mar 2011 | - | $193.30M(-16.1%) |
| Dec 2010 | $230.40M(+11.3%) | $230.40M(+22.6%) |
| Sep 2010 | - | $188.00M(+0.2%) |
| Jun 2010 | - | $187.60M(-7.6%) |
| Mar 2010 | - | $203.10M(-1.9%) |
| Dec 2009 | $207.10M(+24.6%) | $207.10M(+39.5%) |
| Sep 2009 | - | $148.50M(-2.7%) |
| Jun 2009 | - | $152.60M(+2.8%) |
| Mar 2009 | - | $148.40M(-10.7%) |
| Dec 2008 | $166.20M(-50.0%) | $166.20M(+97.0%) |
| Sep 2008 | - | $84.38M(-32.7%) |
| Jun 2008 | - | $125.40M(-58.0%) |
| Mar 2008 | - | $298.26M(-10.3%) |
| Dec 2007 | $332.40M(+537.4%) | $332.40M(+754.4%) |
| Sep 2007 | - | $38.90M(-7.2%) |
| Jun 2007 | - | $41.93M(-24.7%) |
| Mar 2007 | - | $55.69M(+6.8%) |
| Dec 2006 | $52.15M(-16.7%) | $52.15M(+18.1%) |
| Sep 2006 | - | $44.15M(-54.3%) |
| Jun 2006 | - | $96.60M(+44.8%) |
| Mar 2006 | - | $66.70M(+6.5%) |
| Dec 2005 | $62.63M(-19.4%) | $62.63M(-34.3%) |
| Sep 2005 | - | $95.34M(+3.6%) |
| Jun 2005 | - | $92.04M(+8.5%) |
| Mar 2005 | - | $84.82M(+9.2%) |
| Dec 2004 | $77.69M(+1.1%) | $77.69M(+1.4%) |
| Sep 2004 | - | $76.62M(-3.3%) |
| Jun 2004 | - | $79.22M(+3.3%) |
| Mar 2004 | - | $76.67M(-0.2%) |
| Dec 2003 | $76.84M(-9.4%) | $76.84M(+20.3%) |
| Sep 2003 | - | $63.87M(+36.4%) |
| Jun 2003 | - | $46.81M(-4.4%) |
| Mar 2003 | - | $48.97M(-42.3%) |
| Dec 2002 | $84.81M(+911.9%) | $84.81M(+700.0%) |
| Sep 2002 | - | $10.60M(+59.7%) |
| Jun 2002 | - | $6.64M(-1.6%) |
| Mar 2002 | - | $6.74M(-19.5%) |
| Dec 2001 | $8.38M(-61.4%) | $8.38M(+1.4%) |
| Sep 2001 | - | $8.26M(-35.7%) |
| Jun 2001 | - | $12.84M(+5.8%) |
| Mar 2001 | - | $12.14M(-44.1%) |
| Dec 2000 | $21.73M(+789.6%) | $21.73M(-79.2%) |
| Sep 2000 | - | $104.46M(+4497.9%) |
| Jun 2000 | - | $2.27M(-41.8%) |
| Mar 2000 | - | $3.90M |
| Dec 1999 | $2.44M | - |
FAQ
- What is Bruker annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bruker?
- What is Bruker annual cash & cash equivalents year-on-year change?
- What is Bruker quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Bruker?
- What is Bruker quarterly cash & cash equivalents year-on-year change?
What is Bruker annual cash & cash equivalents?
The current annual cash & cash equivalents of BRKR is $183.40M
What is the all time high annual cash & cash equivalents for Bruker?
Bruker all-time high annual cash & cash equivalents is $1.07B
What is Bruker annual cash & cash equivalents year-on-year change?
Over the past year, BRKR annual cash & cash equivalents has changed by -$304.90M (-62.44%)
What is Bruker quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of BRKR is $184.20M
What is the all time high quarterly cash & cash equivalents for Bruker?
Bruker all-time high quarterly cash & cash equivalents is $1.07B
What is Bruker quarterly cash & cash equivalents year-on-year change?
Over the past year, BRKR quarterly cash & cash equivalents has changed by -$155.90M (-45.84%)